{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:51:43Z","timestamp":1793962303440,"version":"4.8.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH-NIDDK","award":["2T32DK007519"],"award-info":[{"award-number":["2T32DK007519"]}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["11000"],"award-info":[{"award-number":["11000"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Miles for Myeloma Fundraiser"},{"name":"IUSM Precision Health Initiative"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple Myeloma (MM) induces bone destruction, decreases bone formation, and increases marrow angiogenesis in patients. We reported that osteocytes (Ocys) directly interact with MM cells to increase tumor growth and expression of Ocy-derived factors that promote bone resorption and suppress bone formation. However, the contribution of Ocys to enhanced marrow vascularization in MM is unclear. Since the MM microenvironment is hypoxic, we assessed if hypoxia and\/or interactions with MM cells increases pro-angiogenic signaling in Ocys. Hypoxia and\/or co-culture with MM cells significantly increased Vegf-a expression in MLOA5-Ocys, and conditioned media (CM) from MLOA5s or MM-MLOA5 co-cultured in hypoxia, significantly increased endothelial tube length compared to normoxic CM. Further, Vegf-a knockdown in MLOA5s or primary Ocys co-cultured with MM cells or neutralizing Vegf-a in MM-Ocy co-culture CM completely blocked the increased endothelial activity. Importantly, Vegf-a-expressing Ocy numbers were significantly increased in MM-injected mouse bones, positively correlating with tumor vessel area. Finally, we demonstrate that direct contact with MM cells increases Ocy Fgf23, which enhanced Vegf-a expression in Ocys. Fgf23 deletion in Ocys blocked these changes. These results suggest hypoxia and MM cells induce a pro-angiogenic phenotype in Ocys via Fgf23 and Vegf-a signaling, which can promote MM-induced marrow vascularization.<\/jats:p>","DOI":"10.1038\/s41598-020-74352-x","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T06:04:52Z","timestamp":1602655492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23"],"prefix":"10.1038","volume":"10","author":[{"given":"Patrick L.","family":"Mulcrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanique K. E.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela N.","family":"Petrusca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Haneline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Delgado-Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. David","family":"Roodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"key":"74352_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7\u201330. https:\/\/doi.org\/10.3322\/caac.21590 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"74352_CR2","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1200\/JCO.2012.47.7901","volume":"31","author":"E Terpos","year":"2013","unstructured":"Terpos, E. et al. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J. Clin. Oncol. 31, 2347\u20132357. https:\/\/doi.org\/10.1200\/JCO.2012.47.7901 (2013).","journal-title":"J. Clin. Oncol."},{"key":"74352_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41408-017-0037-4","volume":"8","author":"E Terpos","year":"2018","unstructured":"Terpos, E., Ntanasis-Stathopoulos, I., Gavriatopoulou, M. & Dimopoulos, M. A. Pathogenesis of bone disease in multiple myeloma: from bench to bedside. Blood Cancer J. 8, 7. https:\/\/doi.org\/10.1038\/s41408-017-0037-4 (2018).","journal-title":"Blood Cancer J."},{"key":"74352_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12761","author":"E Terpos","year":"2017","unstructured":"Terpos, E., Christoulas, D., Gavriatopoulou, M. & Dimopoulos, M. A. Mechanisms of bone destruction in multiple myeloma. Eur. J. Cancer Care (Engl.) https:\/\/doi.org\/10.1111\/ecc.12761 (2017).","journal-title":"Eur. J. Cancer Care (Engl.)"},{"key":"74352_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1182\/bloodadvances.2016002493","volume":"1","author":"LJ Costa","year":"2017","unstructured":"Costa, L. J. et al. Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood Adv. 1, 282\u2013287. https:\/\/doi.org\/10.1182\/bloodadvances.2016002493 (2017).","journal-title":"Blood Adv."},{"key":"74352_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.leu.2404067","volume":"20","author":"A Vacca","year":"2006","unstructured":"Vacca, A. & Ribatti, D. Bone marrow angiogenesis in multiple myeloma. Leukemia 20, 193\u2013199. https:\/\/doi.org\/10.1038\/sj.leu.2404067 (2006).","journal-title":"Leukemia"},{"key":"74352_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00223-013-9794-7","volume":"94","author":"N Kovacic","year":"2014","unstructured":"Kovacic, N., Croucher, P. I. & McDonald, M. M. Signaling between tumor cells and the host bone marrow microenvironment. Calcif. Tissue Int. 94, 125\u2013139. https:\/\/doi.org\/10.1007\/s00223-013-9794-7 (2014).","journal-title":"Calcif. Tissue Int."},{"key":"74352_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00520-008-0418-0","volume":"16","author":"L Costa","year":"2008","unstructured":"Costa, L., Badia, X., Chow, E., Lipton, A. & Wardley, A. Impact of skeletal complications on patients\u2019 quality of life, mobility, and functional independence. Support Care Cancer 16, 879\u2013889. https:\/\/doi.org\/10.1007\/s00520-008-0418-0 (2008).","journal-title":"Support Care Cancer"},{"key":"74352_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11914-016-0315-2","volume":"14","author":"D Buenrostro","year":"2016","unstructured":"Buenrostro, D., Mulcrone, P. L., Owens, P. & Sterling, J. A. The bone microenvironment: a fertile soil for tumor growth. Curr. Osteoporos. Rep. 14, 151\u2013158. https:\/\/doi.org\/10.1007\/s11914-016-0315-2 (2016).","journal-title":"Curr. Osteoporos. Rep."},{"key":"74352_CR10","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1158\/0008-5472.CAN-15-1703","volume":"76","author":"J Delgado-Calle","year":"2016","unstructured":"Delgado-Calle, J. et al. Bidirectional notch signaling and osteocyte-derived factors in the bone marrow microenvironment promote tumor cell proliferation and bone destruction in multiple myeloma. Cancer Res. 76, 1089\u20131100. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1703 (2016).","journal-title":"Cancer Res."},{"key":"74352_CR11","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/leu.2011.381","volume":"26","author":"N Giuliani","year":"2012","unstructured":"Giuliani, N. et al. Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation. Leukemia 26, 1391\u20131401. https:\/\/doi.org\/10.1038\/leu.2011.381 (2012).","journal-title":"Leukemia"},{"key":"74352_CR12","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1182\/blood-2017-03-773341","volume":"129","author":"MM McDonald","year":"2017","unstructured":"McDonald, M. M. et al. Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma. Blood 129, 3452\u20133464. https:\/\/doi.org\/10.1182\/blood-2017-03-773341 (2017).","journal-title":"Blood"},{"key":"74352_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13045-018-0666-5","volume":"11","author":"DN Petrusca","year":"2018","unstructured":"Petrusca, D. N. et al. Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis. J. Hematol. Oncol. 11, 123. https:\/\/doi.org\/10.1186\/s13045-018-0666-5 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"74352_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jbmr.320","volume":"26","author":"LF Bonewald","year":"2011","unstructured":"Bonewald, L. F. The amazing osteocyte. J. Bone Miner. Res. 26, 229\u2013238. https:\/\/doi.org\/10.1002\/jbmr.320 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"74352_CR15","doi-asserted-by":"publisher","first-page":"e10186","DOI":"10.1002\/jbm4.10186","volume":"3","author":"EG Atkinson","year":"2019","unstructured":"Atkinson, E. G. & Delgado-Calle, J. The emerging role of osteocytes in cancer in bone. JBMR Plus 3, e10186. https:\/\/doi.org\/10.1002\/jbm4.10186 (2019).","journal-title":"JBMR Plus"},{"key":"74352_CR16","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1038\/leu.2017.152","volume":"31","author":"J Delgado-Calle","year":"2017","unstructured":"Delgado-Calle, J. et al. Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth. Leukemia 31, 2686\u20132694. https:\/\/doi.org\/10.1038\/leu.2017.152 (2017).","journal-title":"Leukemia"},{"key":"74352_CR17","doi-asserted-by":"publisher","first-page":"19647","DOI":"10.18632\/oncotarget.3794","volume":"6","author":"A Suvannasankha","year":"2015","unstructured":"Suvannasankha, A. et al. FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells. Oncotarget 6, 19647\u201319660. https:\/\/doi.org\/10.18632\/oncotarget.3794 (2015).","journal-title":"Oncotarget"},{"key":"74352_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/jor.21283","volume":"29","author":"WY Cheung","year":"2011","unstructured":"Cheung, W. Y., Liu, C., Tonelli-Zasarsky, R. M., Simmons, C. A. & You, L. Osteocyte apoptosis is mechanically regulated and induces angiogenesis in vitro. J. Orthop. Res. 29, 523\u2013530. https:\/\/doi.org\/10.1002\/jor.21283 (2011).","journal-title":"J. Orthop. Res."},{"key":"74352_CR19","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1038\/sj.onc.1209456","volume":"25","author":"D Ribatti","year":"2006","unstructured":"Ribatti, D., Nico, B. & Vacca, A. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25, 4257\u20134266. https:\/\/doi.org\/10.1038\/sj.onc.1209456 (2006).","journal-title":"Oncogene"},{"key":"74352_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00774-007-0765-9","volume":"25","author":"M Hirao","year":"2007","unstructured":"Hirao, M. et al. Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes. J. Bone Miner. Metab. 25, 266\u2013276. https:\/\/doi.org\/10.1007\/s00774-007-0765-9 (2007).","journal-title":"J. Bone Miner. Metab."},{"key":"74352_CR21","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1038\/s41467-018-04679-7","volume":"9","author":"S Stegen","year":"2018","unstructured":"Stegen, S. et al. Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin. Nat. Commun. 9, 2557. https:\/\/doi.org\/10.1038\/s41467-018-04679-7 (2018).","journal-title":"Nat. Commun."},{"key":"74352_CR22","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1038\/leu.2013.24","volume":"27","author":"P Storti","year":"2013","unstructured":"Storti, P. et al. Hypoxia-inducible factor (HIF)-1alpha suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction. Leukemia 27, 1697\u20131706. https:\/\/doi.org\/10.1038\/leu.2013.24 (2013).","journal-title":"Leukemia"},{"key":"74352_CR23","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/jbmr.3133","volume":"32","author":"PL Mulcrone","year":"2017","unstructured":"Mulcrone, P. L. et al. Skeletal colonization by breast cancer cells is stimulated by an osteoblast and beta2AR-dependent neo-angiogenic switch. J. Bone Miner. Res. 32, 1442\u20131454. https:\/\/doi.org\/10.1002\/jbmr.3133 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"74352_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clml.2013.07.008","volume":"14","author":"EM Sewify","year":"2014","unstructured":"Sewify, E. M., Afifi, O. A., Mosad, E., Zaki, A. H. & El Gammal, S. A. Cyclin D1 amplification in multiple myeloma is associated with multidrug resistance expression. Clin. Lymphoma Myeloma Leuk. 14, 215\u2013222. https:\/\/doi.org\/10.1016\/j.clml.2013.07.008 (2014).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"74352_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2144\/0000113876","volume":"52","author":"AR Stern","year":"2012","unstructured":"Stern, A. R. et al. Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. Biotechniques 52, 361\u2013373. https:\/\/doi.org\/10.2144\/0000113876 (2012).","journal-title":"Biotechniques"},{"key":"74352_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00467-012-2309-3","volume":"28","author":"LF Bonewald","year":"2013","unstructured":"Bonewald, L. F. & Wacker, M. J. FGF23 production by osteocytes. Pediatr. Nephrol. 28, 563\u2013568. https:\/\/doi.org\/10.1007\/s00467-012-2309-3 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"74352_CR27","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/jbmr.2792","volume":"31","author":"EL Clinkenbeard","year":"2016","unstructured":"Clinkenbeard, E. L. et al. Conditional deletion of murine Fgf 23: interruption of the normal skeletal responses to phosphate challenge and rescue of genetic hypophosphatemia. J. Bone Miner. Res. 31, 1247\u20131257. https:\/\/doi.org\/10.1002\/jbmr.2792 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"74352_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2353\/ajpath.2010.091164","volume":"177","author":"H Shimoyamada","year":"2010","unstructured":"Shimoyamada, H. et al. Early growth response-1 induces and enhances vascular endothelial growth factor-A expression in lung cancer cells. Am. J. Pathol. 177, 70\u201383. https:\/\/doi.org\/10.2353\/ajpath.2010.091164 (2010).","journal-title":"Am. J. Pathol."},{"key":"74352_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mvr.2018.01.002","volume":"117","author":"G Karthikkeyan","year":"2018","unstructured":"Karthikkeyan, G. et al. Hyperglycemia induced early growth response-1 regulates vascular dysfunction in human retinal endothelial cells. Microvasc. Res. 117, 37\u201343. https:\/\/doi.org\/10.1016\/j.mvr.2018.01.002 (2018).","journal-title":"Microvasc. Res."},{"key":"74352_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bone.2017.01.034","volume":"102","author":"EL Clinkenbeard","year":"2017","unstructured":"Clinkenbeard, E. L. & White, K. E. Heritable and acquired disorders of phosphate metabolism: etiologies involving FGF23 and current therapeutics. Bone 102, 31\u201339. https:\/\/doi.org\/10.1016\/j.bone.2017.01.034 (2017).","journal-title":"Bone"},{"key":"74352_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara, N., Gerber, H. P. & LeCouter, J. The biology of VEGF and its receptors. Nat. Med. 9, 669\u2013676. https:\/\/doi.org\/10.1038\/nm0603-669 (2003).","journal-title":"Nat. Med."},{"key":"74352_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrm1911","volume":"7","author":"AK Olsson","year":"2006","unstructured":"Olsson, A. K., Dimberg, A., Kreuger, J. & Claesson-Welsh, L. VEGF receptor signalling\u2014in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359\u2013371. https:\/\/doi.org\/10.1038\/nrm1911 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"74352_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"key":"74352_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/jbmr.3599","volume":"34","author":"PJ Stiers","year":"2019","unstructured":"Stiers, P. J. et al. Inhibition of the oxygen sensor PHD2 enhances tissue-engineered endochondral bone formation. J. Bone Miner. Res. 34, 333\u2013348. https:\/\/doi.org\/10.1002\/jbmr.3599 (2019).","journal-title":"J. Bone Miner. Res."},{"key":"74352_CR35","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.bone.2012.01.025","volume":"50","author":"OD Kennedy","year":"2012","unstructured":"Kennedy, O. D. et al. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. Bone 50, 1115\u20131122. https:\/\/doi.org\/10.1016\/j.bone.2012.01.025 (2012).","journal-title":"Bone"},{"key":"74352_CR36","doi-asserted-by":"publisher","first-page":"E389","DOI":"10.1152\/ajpendo.00320.2011","volume":"302","author":"P Juffer","year":"2012","unstructured":"Juffer, P., Jaspers, R. T., Lips, P., Bakker, A. D. & Klein-Nulend, J. Expression of muscle anabolic and metabolic factors in mechanically loaded MLO-Y4 osteocytes. Am. J. Physiol. Endocrinol. Metab. 302, E389-395. https:\/\/doi.org\/10.1152\/ajpendo.00320.2011 (2012).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"74352_CR37","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1038\/bcj.2014.82","volume":"4","author":"B Muz","year":"2014","unstructured":"Muz, B., de la Puente, P., Azab, F., Luderer, M. & Azab, A. K. Hypoxia promotes stem cell-like phenotype in multiple myeloma cells. Blood Cancer J. 4, e262. https:\/\/doi.org\/10.1038\/bcj.2014.82 (2014).","journal-title":"Blood Cancer J."},{"key":"74352_CR38","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1002\/cncr.20697","volume":"101","author":"A Baur","year":"2004","unstructured":"Baur, A., Bartl, R., Pellengahr, C., Baltin, V. & Reiser, M. Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histopathologic findings. Cancer 101, 2599\u20132604. https:\/\/doi.org\/10.1002\/cncr.20697 (2004).","journal-title":"Cancer"},{"key":"74352_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.leukres.2016.05.008","volume":"47","author":"C Niemoller","year":"2016","unstructured":"Niemoller, C. et al. Single cell genotyping of exome sequencing-identified mutations to characterize the clonal composition and evolution of inv(16) AML in a CBL mutated clonal hematopoiesis. Leuk. Res. 47, 41\u201346. https:\/\/doi.org\/10.1016\/j.leukres.2016.05.008 (2016).","journal-title":"Leuk. Res."},{"key":"74352_CR40","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-15-2998","volume":"76","author":"H Naito","year":"2016","unstructured":"Naito, H. et al. Endothelial side population cells contribute to tumor angiogenesis and antiangiogenic drug resistance. Cancer Res. 76, 3200\u20133210. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2998 (2016).","journal-title":"Cancer Res."},{"key":"74352_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neo.2018.10.011","volume":"21","author":"I Saltarella","year":"2019","unstructured":"Saltarella, I. et al. Homotypic and heterotypic activation of the notch pathway in multiple myeloma-enhanced angiogenesis: a novel therapeutic target?. Neoplasia 21, 93\u2013105. https:\/\/doi.org\/10.1016\/j.neo.2018.10.011 (2019).","journal-title":"Neoplasia"},{"key":"74352_CR42","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/leu.2016.3","volume":"30","author":"M Moschetta","year":"2016","unstructured":"Moschetta, M. et al. Targeting vasculogenesis to prevent progression in multiple myeloma. Leukemia 30, 1103\u20131115. https:\/\/doi.org\/10.1038\/leu.2016.3 (2016).","journal-title":"Leukemia"},{"key":"74352_CR43","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/sj.leu.2403084","volume":"17","author":"S Kumar","year":"2003","unstructured":"Kumar, S. et al. Expression of VEGF and its receptors by myeloma cells. Leukemia 17, 2025\u20132031. https:\/\/doi.org\/10.1038\/sj.leu.2403084 (2003).","journal-title":"Leukemia"},{"key":"74352_CR44","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1078-0432.CCR-13-1950","volume":"20","author":"R Ria","year":"2014","unstructured":"Ria, R. et al. HIF-1alpha of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target. Clin. Cancer Res. 20, 847\u2013858. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1950 (2014).","journal-title":"Clin. Cancer Res."},{"key":"74352_CR45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","volume":"8","author":"O Casanovas","year":"2005","unstructured":"Casanovas, O., Hicklin, D. J., Bergers, G. & Hanahan, D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8, 299\u2013309. https:\/\/doi.org\/10.1016\/j.ccr.2005.09.005 (2005).","journal-title":"Cancer Cell"},{"key":"74352_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/0008-5472.CAN-05-1195","volume":"66","author":"AM Roccaro","year":"2006","unstructured":"Roccaro, A. M. et al. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells. Cancer Res. 66, 184\u2013191. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1195 (2006).","journal-title":"Cancer Res."},{"key":"74352_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/cncr.27745","volume":"119","author":"D White","year":"2013","unstructured":"White, D. et al. Results from AMBER, a randomized phase 2 study of bevacizumab and bortezomib versus bortezomib in relapsed or refractory multiple myeloma. Cancer 119, 339\u2013347. https:\/\/doi.org\/10.1002\/cncr.27745 (2013).","journal-title":"Cancer"},{"key":"74352_CR48","doi-asserted-by":"publisher","first-page":"13366","DOI":"10.18632\/oncotarget.24351","volume":"9","author":"L Rao","year":"2018","unstructured":"Rao, L. et al. Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin((R)) protein MP0250: a preclinical study. Oncotarget 9, 13366\u201313381. https:\/\/doi.org\/10.18632\/oncotarget.24351 (2018).","journal-title":"Oncotarget"},{"key":"74352_CR49","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1080\/19420862.2017.1305529","volume":"9","author":"HK Binz","year":"2017","unstructured":"Binz, H. K. et al. Design and characterization of MP0250, a tri-specific anti-HGF\/anti-VEGF DARPin(R) drug candidate. MAbs 9, 1262\u20131269. https:\/\/doi.org\/10.1080\/19420862.2017.1305529 (2017).","journal-title":"MAbs"},{"key":"74352_CR50","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.biomaterials.2017.11.029","volume":"155","author":"CF Mu","year":"2018","unstructured":"Mu, C. F. et al. Targeted drug delivery for tumor therapy inside the bone marrow. Biomaterials 155, 191\u2013202. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.11.029 (2018).","journal-title":"Biomaterials"},{"key":"74352_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030154","author":"H Wang","year":"2018","unstructured":"Wang, H. et al. Synthesis of a bone-targeted bortezomib with in vivo anti-myeloma effects in mice. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics10030154 (2018).","journal-title":"Pharmaceutics"},{"key":"74352_CR52","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/jbmr.3889","volume":"35","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Targeting bortezomib to bone increases its bone anabolic activity and reduces systemic adverse effects in mice. J. Bone Miner. Res. 35, 343\u2013356. https:\/\/doi.org\/10.1002\/jbmr.3889 (2020).","journal-title":"J. Bone Miner. Res."},{"key":"74352_CR53","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.celrep.2019.12.013","volume":"30","author":"B He","year":"2020","unstructured":"He, B. et al. Remodeling of metastatic vasculature reduces lung colonization and sensitizes overt metastases to immunotherapy. Cell Rep. 30, 714\u2013724. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.013 (2020).","journal-title":"Cell Rep."},{"key":"74352_CR54","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1158\/1078-0432.CCR-06-2258","volume":"13","author":"Y Tanaka","year":"2007","unstructured":"Tanaka, Y. et al. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin. Clin. Cancer Res. 13, 816\u2013823. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2258 (2007).","journal-title":"Clin. Cancer Res."},{"key":"74352_CR55","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1182\/blood-2009-08-237628","volume":"115","author":"FC Cackowski","year":"2010","unstructured":"Cackowski, F. C. et al. Osteoclasts are important for bone angiogenesis. Blood 115, 140\u2013149. https:\/\/doi.org\/10.1182\/blood-2009-08-237628 (2010).","journal-title":"Blood"},{"key":"74352_CR56","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature13145","volume":"507","author":"AP Kusumbe","year":"2014","unstructured":"Kusumbe, A. P., Ramasamy, S. K. & Adams, R. H. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507, 323\u2013328. https:\/\/doi.org\/10.1038\/nature13145 (2014).","journal-title":"Nature"},{"key":"74352_CR57","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature13146","volume":"507","author":"SK Ramasamy","year":"2014","unstructured":"Ramasamy, S. K., Kusumbe, A. P., Wang, L. & Adams, R. H. Endothelial notch activity promotes angiogenesis and osteogenesis in bone. Nature 507, 376\u2013380. https:\/\/doi.org\/10.1038\/nature13146 (2014).","journal-title":"Nature"},{"key":"74352_CR58","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1242\/dev.136861","volume":"143","author":"KK Sivaraj","year":"2016","unstructured":"Sivaraj, K. K. & Adams, R. H. Blood vessel formation and function in bone. Development 143, 2706\u20132715. https:\/\/doi.org\/10.1242\/dev.136861 (2016).","journal-title":"Development"},{"key":"74352_CR59","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/carcin\/bgs386","volume":"34","author":"J Zhang","year":"2013","unstructured":"Zhang, J. et al. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch\/Dll4 pathway. Carcinogenesis 34, 667\u2013677. https:\/\/doi.org\/10.1093\/carcin\/bgs386 (2013).","journal-title":"Carcinogenesis"},{"key":"74352_CR60","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3892\/or_00000712","volume":"23","author":"S Zang","year":"2010","unstructured":"Zang, S. et al. RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer. Oncol. Rep. 23, 893\u2013899. https:\/\/doi.org\/10.3892\/or_00000712 (2010).","journal-title":"Oncol. Rep."},{"key":"74352_CR61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4149\/neo_2013_005","volume":"60","author":"D Guo","year":"2013","unstructured":"Guo, D. et al. Notch1 overexpression promotes cell growth and tumor angiogenesis in myeloma. Neoplasma 60, 33\u201340. https:\/\/doi.org\/10.4149\/neo_2013_005 (2013).","journal-title":"Neoplasma"},{"key":"74352_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbo.2018.09.002","volume":"13","author":"L Cl\u00e9ment-Demange","year":"2018","unstructured":"Cl\u00e9ment-Demange, L., Mulcrone, P. L., Tabarestani, T. Q., Sterling, J. A. & Elefteriou, F. beta2ARs stimulation in osteoblasts promotes breast cancer cell adhesion to bone marrow endothelial cells in an IL-1beta and selectin-dependent manner. J. Bone Oncol. 13, 1\u201310. https:\/\/doi.org\/10.1016\/j.jbo.2018.09.002 (2018).","journal-title":"J. Bone Oncol."},{"key":"74352_CR63","doi-asserted-by":"publisher","first-page":"e93840","DOI":"10.1371\/journal.pone.0093840","volume":"9","author":"K Miyagawa","year":"2014","unstructured":"Miyagawa, K. et al. Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice. PLoS ONE 9, e93840. https:\/\/doi.org\/10.1371\/journal.pone.0093840 (2014).","journal-title":"PLoS ONE"},{"key":"74352_CR64","doi-asserted-by":"publisher","first-page":"17291","DOI":"10.18632\/oncotarget.4174","volume":"6","author":"S Feng","year":"2015","unstructured":"Feng, S., Wang, J., Zhang, Y., Creighton, C. J. & Ittmann, M. FGF23 promotes prostate cancer progression. Oncotarget 6, 17291\u201317301. https:\/\/doi.org\/10.18632\/oncotarget.4174 (2015).","journal-title":"Oncotarget"},{"key":"74352_CR65","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/bcp.13763","volume":"85","author":"EA Imel","year":"2019","unstructured":"Imel, E. A. & White, K. E. Pharmacological management of X-linked hypophosphataemia. Br. J. Clin. Pharmacol. 85, 1188\u20131198. https:\/\/doi.org\/10.1111\/bcp.13763 (2019).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"74352_CR66","doi-asserted-by":"publisher","first-page":"C502","DOI":"10.1152\/ajpcell.00137.2018","volume":"315","author":"KM Varberg","year":"2018","unstructured":"Varberg, K. M. et al. Transgelin induces dysfunction of fetal endothelial colony-forming cells from gestational diabetic pregnancies. Am. J. Physiol. Cell Physiol. 315, C502\u2013C515. https:\/\/doi.org\/10.1152\/ajpcell.00137.2018 (2018).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"74352_CR67","doi-asserted-by":"publisher","first-page":"12635","DOI":"10.1038\/srep12635","volume":"5","author":"J Preston Campbell","year":"2015","unstructured":"Preston Campbell, J. et al. TRIzol and Alu qPCR-based quantification of metastatic seeding within the skeleton. Sci. Rep. 5, 12635. https:\/\/doi.org\/10.1038\/srep12635 (2015).","journal-title":"Sci. Rep."},{"key":"74352_CR68","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bone.2014.12.012","volume":"73","author":"AY Sato","year":"2015","unstructured":"Sato, A. Y., Tu, X., McAndrews, K. A., Plotkin, L. I. & Bellido, T. Prevention of glucocorticoid induced-apoptosis of osteoblasts and osteocytes by protecting against endoplasmic reticulum (ER) stress in vitro and in vivo in female mice. Bone 73, 60\u201368. https:\/\/doi.org\/10.1016\/j.bone.2014.12.012 (2015).","journal-title":"Bone"},{"key":"74352_CR69","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.celrep.2019.04.072","volume":"27","author":"JS Harding","year":"2019","unstructured":"Harding, J. S. et al. VEGF-A from granuloma macrophages regulates granulomatous inflammation by a non-angiogenic pathway during mycobacterial infection. Cell Rep. 27, 2119\u20132131. https:\/\/doi.org\/10.1016\/j.celrep.2019.04.072 (2019).","journal-title":"Cell Rep."},{"key":"74352_CR70","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/acel.12586","volume":"16","author":"HM Davis","year":"2017","unstructured":"Davis, H. M. et al. Disruption of the Cx43\/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging. Aging Cell 16, 551\u2013563. https:\/\/doi.org\/10.1111\/acel.12586 (2017).","journal-title":"Aging Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74352-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74352-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74352-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T16:19:09Z","timestamp":1670343549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74352-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["74352"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-74352-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"10 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17319"}}